How Is the Price of Cancer Drugs Determined in 2026?

Cancer drug prices vary so much by cancer type, drug, and number of cycles that no single fixed figure can be quoted — apart from the KRW 1,000,000 remote review (pre-arrival review) fee, every treatment cost is confirmed through an individual estimate issued by the hospital.

Key Takeaways

• Prices for cancer drugs (chemotherapy, targeted therapy, immunotherapy) vary widely in total depending on the cancer type, the specific drug, and the number of cycles — so apart from the KRW 1,000,000 remote review (pre-arrival review) fee noted here, every other treatment cost is finalized only through an individual estimate issued by the hospital.
• The KRW 1,000,000 remote review (pre-arrival review) fee is deducted from the treatment cost once a treatment contract is signed.
• Treatment estimates break down costs by category — tests, drug costs, hospitalization, and so on — and for drug therapy, the first cycle and subsequent cycles are listed separately.
• Length of stay in Korea depends on the cancer type and treatment approach. For example, targeted therapy (combining workup and the first cycle) often targets 2–3 weeks, and lung cancer drug therapy often targets about 2–3 weeks for the first cycle alone.
• Since the drugs used depend on biomarker test results (EGFR, ALK, HER2, RAS, BRAF, etc.) that guide drug selection, confirming the biomarker results comes before any discussion of price.

Why isn't the price of cancer drugs given as a single fixed amount?

• Because cancer drug costs vary so much from patient to patient, they are not quoted as a fixed figure but are finalized through a hospital estimate. As the source material states, for targeted therapy, 'the total cost varies significantly depending on the drug and the number of cycles, so it is finalized through a hospital estimate' — and the same approach applies to lung cancer, colorectal cancer, and blood cancers.
• For example, in lung cancer, drug therapy estimates separate the first cycle from subsequent cycles, while for blood cancers, the estimate itemizes testing, chemotherapy, transplant (conditioning regimen, the transplant itself, the sterile unit, immunosuppressants, donor testing), drug costs, as well as interpretation, accommodation, and transportation.
• In short, 'the price of a cancer drug' isn't a single number — it's a composite figure that depends on which cancer is involved, which subtype and biomarkers are present, how many cycles of treatment are needed, and whether hospitalization is required.

What is the process for finding out drug treatment costs?

• Step 1: Organize your existing medical records — pathology and genetic test results, imaging, and medication history — from your home country.
• Step 2: Request a remote review (pre-arrival review) (fee: KRW 1,000,000). Based on your cancer type and biomarker results, this confirms which treatment drugs may be applicable and under what conditions.
• Step 3: Once you sign a treatment contract, the KRW 1,000,000 remote review (pre-arrival review) fee is deducted from your treatment cost, and the hospital provides an estimate (견적서) itemizing tests, drug costs, hospitalization, interpretation, accommodation, transportation, and more.
• Step 4: Based on the estimate, you and the hospital jointly plan your stay — for instance, deciding whether to start the first cycle in Korea and continue subsequent cycles back home.

FAQ — Why does the cost of targeted therapy drugs differ so much from person to person?

Targeted therapy selects drugs based on confirmed biomarkers such as EGFR, ALK, HER2, RAS, and BRAF — so even patients with the same type of cancer may be prescribed different drugs if their biomarkers differ. The total cost varies depending on the form of the drug (oral inhibitor, antibody infusion, or antibody-drug conjugate) and the number of treatment cycles, which is why the source material notes that 'the total cost varies significantly depending on the drug and the number of cycles, so it is finalized through a hospital estimate.' Length of stay, including workup and the first cycle, is often planned for 2–3 weeks.

FAQ — How does the remote review (pre-arrival review) fee differ from the actual treatment cost?

The remote review (pre-arrival review) is a pre-treatment step that reviews your existing test results to confirm which treatments and conditions may apply; it costs KRW 1,000,000, and this amount is deducted from your treatment cost once you sign a treatment contract. The actual treatment cost — drugs, hospitalization, transplant, interpretation, accommodation, and so on — varies depending on the cancer type, stage, drug, and number of cycles, so it can only be finalized through an individual estimate (견적서) issued by the hospital.

Sources and Notes

• This article was prepared based on National Cancer Registration Statistics 2019–2023 (National Cancer Center Korea), NCCN patient guidelines, the National Cancer Information Center, U.S. National Cancer Institute (NCI) materials, and the platform's confirmed cost policy (KRW 1,000,000 remote review/pre-arrival review fee).
• This content is provided for general medical information purposes only. Diagnosis, treatment methods, and outcomes may vary depending on an individual's condition. Accurate diagnosis and treatment decisions should always be made in consultation with a medical professional.